Coronavirus disease 2019 (COVID-19) vaccination in systemic lupus erythematosus and anti-neutrophil cytoplasmic antibody-associated vasculitis
- 29 April 2021
- journal article
- letter
- Published by Springer Science and Business Media LLC in Clinical Rheumatology
- Vol. 40 (6), 2517-2518
- https://doi.org/10.1007/s10067-021-05750-3
Abstract
No abstract availableThis publication has 10 references indexed in Scilit:
- A practical approach for vaccinations including COVID-19 in autoimmune/autoinflammatory rheumatic diseases: a non-systematic reviewClinical Rheumatology, 2021
- American College of Rheumatology Guidance for COVID‐19 Vaccination in Patients With Rheumatic and Musculoskeletal Diseases: Version 1Arthritis & Rheumatology, 2021
- Vaccine hesitancy in the era of COVID-19: could lessons from the past help in divining the future?Human Vaccines & Immunotherapeutics, 2021
- COVID-19 Vaccine Hesitancy Worldwide: A Concise Systematic Review of Vaccine Acceptance RatesVaccines, 2021
- Kidney disease is associated with in-hospital death of patients with COVID-19Kidney International, 2020
- Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort studyThe Lancet, 2020
- Epidemiology and risk factors for cytomegalovirus infection in glomerular diseases treated with immunosuppressive therapyNephrology, 2018
- Vaccination coverage in systemic lupus erythematosus—a cross-sectional analysis of the German long-term study (LuLa cohort)Rheumatology, 2018
- Severe infections in patients with lupus nephritis treated with immunosuppressants: A retrospective cohort studyNephrology, 2017
- Attitude, knowledge and factors associated with influenza and pneumococcal vaccine uptake in a large cohort of patients with secondary immune deficiencyVaccine, 2015